Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicensePlus Black IconRevocationPlus Black IconReissuePlus Black IconCorrected translationPlus Black IconSPC

EP3411029

Súksínatsalt sýtisíns og notkun þess

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    6.2.2017
  • EP published:
    1.11.2023
  • EP application number:
    17704814.7
  • Max expiry date:
    5.2.2037
  • Expiry date:
    5.2.2027
  • Next due date:
    28.2.2027
  • Title in English:
    SUCCINATE SALT OF CYTISINE AND USE THEREOF
  • Language of the patent:
    English

Timeline

Today
6.2.2017EP application
1.11.2023EP Publication
23.11.2023Translation submitted
15.12.2023Registration published
5.2.2027Expires

Owner

  • Name:
    Achieve Pharma UK Limited
  • Address:
    10 Station Road, Henley-on-Thames, Oxfordshire RG9 1AY, GB

Inventor

  • Name:
    CLARKE, Anthony
  • Address:
    Henley-on-Thames Oxfordshire RG9 1AY, GB
  • Name:
    STEWART, Richard Allistair
  • Address:
    Henley-on-Thames Oxfordshire RG9 1AY, GB
  • Name:
    WILLIS, Andrew Gareth
  • Address:
    Usk NP15 1AB, GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201602145
  • Date:
    5.2.2016
  • Country:
    GB

Classification

  • Categories:
    A61K 31/439, A61P 25/34

Annual fees

Number

Paid

Expires

Payer

Number: 8

Paid: 1.12.2023

Expires: 5.2.2025

Payer: Árnason Faktor ehf.

Number: 9

Paid: 10.2.2025

Expires: 5.2.2026

Payer: Árnason Faktor ehf.

Number: 10

Paid: 12.1.2026

Expires: 5.2.2027

Payer: Árnason Faktor ehf.

Upload documents